Multiple Sclerosis Research Studies
Open access
Peer reviewed
Scollr summary
What this paper is about
NIS management significantly improves outcomes in NMOSD patients, as evidenced by lower relapse rates, reduced disability scores, and higher utilization of advanced therapeutics.
Full abstract
Read the full abstract
BACKGROUND: Neuromyelitis optica spectrum disorder (NMOSD) is a severe autoimmune inflammatory disease of the central nervous system (CNS) that requires specialized management. Although the role of subspecialty management has been established in various neurological conditions, the impact of neuroimmunology subspecialty (NIS) management on NMOSD patient outcomes remains inadequately explored. METHODS: A retrospective analysis was conducted on 188 NMOSD patients, stratifying them into groups based on their management pathway: initial visit in NIS, initial visit in non-neuroimmunology subspecialty (NNIS), NNIS-to-NIS transfer, and last visit in either NIS or NNIS. Primary outcome measures included annualized relapse rate (ARR), Expanded Disability Status Scale (EDSS) scores. RESULTS: Patients initially presenting to NIS IV demonstrated a lower ARR (median: 0.39, IQR: 0.31-0.51, 95% confidence interval (CI): 0.33-0.45) compared to other groups at last follow-up. For transfer patients, ARR significantly decreased post-transfer (p < 0.001). Patients in NIS IV group had the lowest EDSS scores (median: 1.3, IQR: 1.0-2.0, 95% CI: 1.0-2.0) compared to other groups. Both initial presentation to NIS (OR:0.50, 95%CI:0.26-0.97, p = 0.039) and subsequent transfer to NIS management (OR:0.41, 95%CI:0.21-0.81, p = 0.010) were associated with lower EDSS scores. CONCLUSION: NIS management significantly improves outcomes in NMOSD patients, as evidenced by lower relapse rates, reduced disability scores, and higher utilization of advanced therapeutics.
Direct answer
What can I do from this paper page?
Use this page to scan "The role of neuroimmunology subspecialty in disease management of patients with neuromyelitis optica spectrum disorder" quickly: start with the summary and abstract, then check the authors, source, topics, and related papers. From here, open Scollr to follow Multiple Sclerosis Research Studies, save the paper, or map adjacent work.
Research areas
Follow related topics
Citation
BibTeX
@article{Xue2026role,
title = {The role of neuroimmunology subspecialty in disease management of patients with neuromyelitis optica spectrum disorder},
author = {Binbin Xue and Jia Li (160557) and Dewei Xie and Xu Zhang (49484) and Junhui Xia and Xiang Li and Jie Lin},
journal = {Orphanet Journal of Rare Diseases},
year = {2026},
doi = {10.1186/s13023-026-04443-x},
url = {https://doi.org/10.1186/s13023-026-04443-x}
}FAQ
Using this paper in a discovery workflow
How do I find related work for this paper?
Use the related papers and topic links on this page as starting points. In Scollr, you can also open the paper and build a literature map around its references, citing papers, and related work.
How can I keep up with new Multiple Sclerosis Research Studies papers?
Follow Multiple Sclerosis Research Studies in Scollr. New papers from the topic flow into a personalized feed, and you can save useful studies to revisit later.
Can I cite this paper from this page?
This page includes a static BibTeX block for The role of neuroimmunology subspecialty in disease management of patients with neuromyelitis optica spectrum disorder. Always verify the DOI, source, and publication details against the publisher record before submitting a manuscript.
Follow this research in Scollr
Follow the topics and authors behind this paper, save useful studies, and build a literature map when you are ready to go deeper.
Get the app